Autolus Therapeutics plc (AUTL) Profit Margins
Over the twelve months to 2026-06-30, Autolus Therapeutics plc (AUTL) had operating margin -210.8%, net margin -238.7%, free cash flow margin -198.3%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AUTLAutolus Therapeutics plcFollow AUTL — free
—
Price chart with a free account
- Market cap
- 409.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2018 Sep 18 | FY2019 Dec 19 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | -12.5% | -27.8% | — | |
| Operating margin | — | -5022.8% | -10583.1% | -2385.6% | -358.9% | -210.8% | |
| Net margin | -3180.6% | -4258.9% | -12272.3% | -2180.5% | -381.4% | -238.7% | |
| FCF margin | -2889.6% | -4120.5% | -9221.0% | -2256.4% | -401.4% | -198.3% |
USD millions · SEC XBRL
Autolus Therapeutics plc — questions
- What is Autolus Therapeutics plc's operating margin?
- -210.8% over the twelve months to 2026-06-30.
- What is Autolus Therapeutics plc's net profit margin?
- -238.7% over the twelve months to 2026-06-30.
Every figure on this page comes from Autolus Therapeutics plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.